Has Franco de Monte, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,732 in general payments to Franco de Monte, MD across 52 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Franco de Monte, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Franco de Monte, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Franco de Monte, MD

Neurological Surgery · Houston, TXNPI 1063518819

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,720 of the $26,732 with a category attached, or 77.5%. Medtronic accounts for 99.4% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $25,036, more than ten times the $135 reported in 2019.

$26,732in general payments, 2019–2025

Across 52 payments — averaging $514.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$27K
Novocure Inc.$135
Stryker$23

$56,520in research payments, 2019–2025

Across 1 payment — averaging $56,520 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

NX Development Corp.$57K

What the payments were for

Speaking & faculty fees$20,72078%
Travel & lodging$4,89918%
Food & beverage$1,1134%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	50	$26,574
Novocure Inc.	1	$135
Stryker	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,732 in reported general payments places this provider in the 80th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$61,709

Medicare patients

Services billed

127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Houston

Andrew RoeserHouston$660K
Paul HolmanHouston$516K
Taylor GistHouston$447K
Meng HuangHouston$324K
Laurence RhinesHouston$322K
Omar TanweerHouston$254K
Jeremy WangHouston$231K
Alexander RopperHouston$208K
Fangyi ZhangHouston$192K
Ashwin ViswanathanHouston$185K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →